跳至主要内容
临床试验/NCT00050622
NCT00050622已完成不适用

ADHD Treatment: Comparative and Combined Dosage Effects

Florida International University2 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2001年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
154
试验地点
2
主要终点
Social Behavior-Negative Verbalizations

研究概览

简要总结

The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). This study will also examine the interactions between different levels of behavioral and drug treatments.

详细描述

Participants attend a summer treatment program each Monday-Friday for 9 weeks. They participate in group recreational and classroom activities, with 12 children and 5 staff per group. Three behavioral conditions (no behavioral modification, low-intensity behavioral modification, and high-intensity behavioral modification) are delivered in random order, with each condition lasting 3 weeks. Along with the behavioral treatment conditions, children receive 1 of 4 medication doses (placebo, 0.15 mg/kg methylphenidate, 0.3 mg/kg methylphenidate, or 0.6 mg/kg methylphenidate) in random order, with each dose varied daily and repeated 3 or 4 times within each behavioral treatment condition.

Measures include frequency counts of positive and negative behaviors, academic productivity and accuracy in the classroom, and counselor, parent, and teacher ratings of benefits and side effects. Parents attend training sessions and implement behavioral programs at home.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
5 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Attention Deficit Hyperactivity Disorder
  • IQ >= 80

排除标准

  • History of seizures or other neurological problems
  • Medical history that would involve considerable risk in taking stimulant medication
  • History or concurrent diagnosis of any of the following disorders: pervasive developmental disorder, schizophrenia or other psychotic disorders, sexual disorder, organic mental disorder, or eating disorder

研究组 & 干预措施

No Treatment

Placebo Comparator

No Medication, No Behavior Modification (BMOD)

干预措施: Placebo (Drug)

Low Dose Medication Only

Active Comparator

0.15 mg/kg methylphenidate (MPH), No BMOD

干预措施: Methylphenidate 0.15 mg/kg (Drug)

Medium Dose Medication Only

Active Comparator

0.3 mg/kg MPH, No BMOD

干预措施: Methylphenidate 0.3 mg/kg (Drug)

High Intensity BMOD + Medium Dose Medication

Active Comparator

0.3 mg/kg MPH, High Intensity BMOD

干预措施: High Intensity BMOD (Behavioral)

Higher Dose Medication Only

Active Comparator

0.6 mg/kg MPH, No BMOD

干预措施: Methylphenidate 0.6 mg/kg (Drug)

Low Intensity BMOD Only

Active Comparator

Placebo, Low Intensity BMOD

干预措施: Low-Intensity BMOD (Behavioral)

Low Intensity BMOD Only

Active Comparator

Placebo, Low Intensity BMOD

干预措施: Placebo (Drug)

Low Intensity BMOD + Low Dose Medication

Active Comparator

0.15 mg/kg MPH, Low Intensity BMOD

干预措施: Methylphenidate 0.15 mg/kg (Drug)

Low Intensity BMOD + Low Dose Medication

Active Comparator

0.15 mg/kg MPH, Low Intensity BMOD

干预措施: Low-Intensity BMOD (Behavioral)

Low Intensity BMOD + Medium Dose Medication

Active Comparator

0.3 mg/kg MPH, Low Intensity BMOD

干预措施: Low-Intensity BMOD (Behavioral)

Low Intensity BMOD + Medium Dose Medication

Active Comparator

0.3 mg/kg MPH, Low Intensity BMOD

干预措施: Methylphenidate 0.3 mg/kg (Drug)

Low Intensity BMOD + Higher Dose Medication

Active Comparator

0.6 mg/kg MPH, Low Intensity BMOD

干预措施: Low-Intensity BMOD (Behavioral)

Low Intensity BMOD + Higher Dose Medication

Active Comparator

0.6 mg/kg MPH, Low Intensity BMOD

干预措施: Methylphenidate 0.6 mg/kg (Drug)

High Intensity BMOD Only

Active Comparator

Placebo, High Intensity BMOD

干预措施: High Intensity BMOD (Behavioral)

High Intensity BMOD + Low Dose Medication

Active Comparator

0.15 mg/kg MPH, High Intensity BMOD

干预措施: Methylphenidate 0.15 mg/kg (Drug)

High Intensity BMOD + Low Dose Medication

Active Comparator

0.15 mg/kg MPH, High Intensity BMOD

干预措施: High Intensity BMOD (Behavioral)

High Intensity BMOD + Medium Dose Medication

Active Comparator

0.3 mg/kg MPH, High Intensity BMOD

干预措施: Methylphenidate 0.3 mg/kg (Drug)

High Intensity BMOD + Higher Dose Medication

Active Comparator

0.6 mg/kg MPH, High Intensity BMOD

干预措施: Methylphenidate 0.6 mg/kg (Drug)

High Intensity BMOD + Higher Dose Medication

Active Comparator

0.6 mg/kg MPH, High Intensity BMOD

干预措施: High Intensity BMOD (Behavioral)

结局指标

主要结局

Social Behavior-Negative Verbalizations

时间窗: Daily for 45 days

Sum of daily frequency of Verbal Abuse toward staff members, Teasing toward peers, and Cursing/Swearing as defined by a behavioral point system that doubles as an objective measure of children's behavior. All instances of these behaviors were reported and noted as they occur throughout daily activities.

Classroom Behavior

时间窗: Daily for 45 days

Daily records of percentage of assigned problems completed by children in a 60-minute classroom period.

次要结局

  • Treatment Satisfaction(End of Treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验